Zenosense | ZENO: MRSA Detection & Protection

Zenosense Inc. is the holder of an exclusive global license agreement to develop and market a device for use in hospitals to detect the Methicillin-resistant Staphylococcus aureus “Super-Bug” (MRSA).

Zenosense has an outsourced development model, contracting-out device development to a known sensor developer with the capability to produce such a sophisticated device.